全球心房颤动市场规模、份额、成长分析，依技术（射频、雷射）、最终用户（医院、专科诊所）- 2024-2031 年产业预测

Global Atrial Fibrillation Market Size, Share, Growth Analysis, By Technology(Radiofrequency, Laser), By End User(Hospitals, Specialty Clinics) - Industry Forecast 2024-2031

出版日期: 2024年05月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年，全球心房颤动市场规模为101.0亿美元，预计将从2023年的113.1亿美元成长到2031年的279.2亿美元，预测期内（2024-2031年）复合年增长率为11.96%。

心房颤动 (AFib) 的特征是心律不规则且通常较快，也称为心律不整，会导致心臟内形成血栓。老年人发病率上升、技术进步以及越来越倾向于导管消融作为治疗选择等因素推动了 AFib 市场的成长。然而，挑战包括缺乏熟练的专家和高昂的治疗费用。儘管如此，市场仍受到雷射和射频应用等创新的推动，这可能会减少对特定 AFib 设备的需求。此外，药物和设备的联合使用在改善心律不整管理方面显示出希望。随着 AFib 盛行率的不断增加，特别是在全球老化人口中，预计市场将大幅扩大。例如，在美国，目前估计有300 至600 万人患有AFib，预计到2050 年将增加到600 到1600 万，而在欧洲，AFib 患病率预计将从2010 年的900 万增加到2060 年的1400 万据预测，到 2050 年，在亚洲，至少有 7200 万人被诊断为 AFib。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2023 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率 (%), 2023

主要公司简介

AtriCure Inc
MicroPort Scientific Corporation
Koninklijke Philips NV
Medtronic plc
Biotronik SE & Co. KG
Johnson & Johnson
Abbott Laboratories
Boston Scientific Corporation
St. Jude Medical
Siemens AG
Endoscopic Technologies Inc.
Boehringer Ingelheim GmbH
Biosense Webster Inc.
CardioFocus Inc.
Sanofi-Aventis
Bristol-Myers Squibb Corporation

简介目录

Product Code: SQMIG35E2044

Global Atrial Fibrillation Market size was valued at USD 10.10 billion in 2022 and is poised to grow from USD 11.31 billion in 2023 to USD 27.92 billion by 2031, at a CAGR of 11.96% during the forecast period (2024-2031).

Atrial fibrillation (AFib), characterized by irregular and often rapid heart rhythms, also termed an arrhythmia, leads to the formation of blood clots within the heart. The growth of the AFib market is fueled by factors such as the rising incidence among the elderly, technological advancements, and a growing preference for catheter ablation as a treatment option. Challenges, however, include a scarcity of skilled specialists and the high cost of treatment. Despite this, the market is driven by innovations like laser and radiofrequency applications, potentially reducing the need for specific AFib devices. Additionally, the combined use of medications and devices shows promise in improving cardiac arrhythmia management. With the increasing prevalence of AFib, particularly among aging populations globally, the market is anticipated to expand significantly. For instance, in the U.S., current estimates suggest 3 to 6 million individuals living with AFib, projected to rise to 6 to 16 million by 2050, while in Europe, AFib prevalence is expected to increase from 9 million in 2010 to 14 million by 2060, and in Asia, AFib diagnoses may encompass at least 72 million individuals by 2050, according to projections.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Atrial Fibrillation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Atrial Fibrillation Market Segmental Analysis

The global atrial fibrillation market is segmented based on technology, end user, and region. The market is segmented based on technology into radiofrequency, laser, cryotherapy, and others. others include ultrasound ablation and electroporation therapy. By end user, the market is categorized into hospitals, specialty clinics, and others. Region-wise, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Atrial Fibrillation Market

The increasing elderly demographic serves as the primary catalyst for growth in the atrial fibrillation market, given their susceptibility to the condition. According to the World Health Organization (WHO), the global population aged 60 and above is estimated to reach one in six individuals by 2030, marking a significant demographic shift. This age group is expected to increase from 1 billion in 2020 to 1.4 billion by 2030, and by 2050, it is projected to double to 2.1 billion. Moreover, there is an anticipated threefold rise in the population aged 80 and above, reaching 426 million by 2050. These demographic trends highlight the profound aging trajectory shaping the world's population in the forthcoming decades.

Restraints in the Global Atrial Fibrillation Market

The significant expense associated with treating atrial fibrillation poses a notable obstacle to the expansion of the market for this condition. As reported by Science Direction, the average expenditure per patient stands at USD 3,530 (95% CI $3,328-$3,732) for hospitalizations, USD 3,878 (95% CI $3,769-$3,987) for outpatient facility visits, and $394 (95% CI $358-$430) for emergency room visits. Consequently, the considerable financial burden of treatment serves as a deterrent to the growth of the atrial fibrillation market.

Market Trends of the Global Atrial Fibrillation Market

The global prevalence of atrial fibrillation (AFib) has surged significantly, becoming a prominent trend in healthcare. With approximately 37.57 million individuals affected worldwide, representing 0.51% of the global population, according to the National Institutes of Health, there has been a remarkable 33% increase in AFib incidence over the last two decades. While nations with higher socio-demographic indexes typically bear the greatest burden, recent data highlights a substantial rise in countries with middle indexes. This shift underscores the dynamic nature of AFib's global landscape, reflecting changes in prevalence across various demographic indicators. Furthermore, the prevalence is fueled by factors like obesity, hypertension, and diabetes, common in contemporary lifestyles, thereby influencing market dynamics.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Atrial Fibrillation Market by Technology

Market Overview
Radiofrequency
Laser
Cryotherapy
and Others

Global Atrial Fibrillation Market by End User

Market Overview
Hospitals
Specialty Clinics
Others

Global Atrial Fibrillation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

AtriCure Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endoscopic Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biosense Webster Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardioFocus Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi-Aventis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments